CLAVULANATE POTASSIUM

Clavulanate potassium inhibits β‑lactamase enzymes, restoring the effectiveness of penicillin antibiotics. Benefits include expanded antibacterial coverage. Side effects include diarrhea and allergic reactions.

SKU: c9de85e783b7 Category: Tag:

Product Description


Mechanism of Action

Potassium clavulanate is a β‑lactamase inhibitor that irreversibly acylates serine β‑lactamases, preventing hydrolysis of β‑lactam antibiotics. As a “suicide inhibitor,” it binds the enzyme and undergoes rearrangement, forming a stable inactive complex. It protects penicillins from degradation by common plasmid‑encoded β‑lactamases.

Benefits and Advantages

Used in β‑lactamase‑mechanism studies, inhibitor–enzyme kinetics research, combination‑antibiotic development, resistance‑pathway modelling and synergy assays with penicillins.

Side Effects and Risks

Risks include hepatic enzyme elevation, hypersensitivity, GI upset and rare cholestatic jaundice. Handle with β‑lactam inhibitor precautions.

Datasheet


Molecular Formula

C8H8KNO5

Molecular Weight

237.25 g/mol

CAS Number

61177-45-5

Storage Condition

Store in a cool, dry place. Keep container tightly closed. Protect from moisture and light.

Solubility

3.37e+02 g/L

Purity

Purity information is available upon request (COA).

Synonym

Potassium clavulanate; 61177-45-5; CLAVULANATE POTASSIUM; Amonate; BRL 14151K

IUPAC/Chemical Name

potassium (2R,3Z,5R)-3-(2-hydroxyethylidene)-7-oxo-4-oxa-1-azabicyclo[3.2.0]heptane-2-carboxylate

InChl Key

ABVRVIZBZKUTMK-JSYANWSFSA-M

InChl Code

InChI=1S/C8H9NO5.K/c10-2-1-4-7(8(12)13)9-5(11)3-6(9)14-4;/h1,6-7,10H,2-3H2,(H,12,13);/q;+1/p-1/b4-1-;/t6-,7-;/m1./s1

References

https://pubchem.ncbi.nlm.nih.gov/compound/23665591;

3D Conformer.

(Click, turn or enlarge)

Download our GMP API Product List.

MedicaPharma is an EU-based supplier of GMP-certified APIs that serves leading healthcare institutions and research organizations.
Click here to download our full API product list.

Download